SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410939-20-000044
Filing Date
2020-11-03
Accepted
2020-11-03 16:24:37
Documents
59
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q opht-20200930.htm   iXBRL 10-Q 1754560
2 EX-31.1 isee9302020exhibit311.htm EX-31.1 11427
3 EX-31.2 isee9302020exhibit312.htm EX-31.2 11662
4 EX-32.1 isee9302020exhibit321.htm EX-32.1 6462
5 EX-32.2 isee9302020exhibit322.htm EX-32.2 6554
11 opht-20200930_g1.jpg GRAPHIC 135569
  Complete submission text file 0001410939-20-000044.txt   6331833

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opht-20200930.xsd EX-101.SCH 36385
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opht-20200930_cal.xml EX-101.CAL 47216
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opht-20200930_def.xml EX-101.DEF 214441
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opht-20200930_lab.xml EX-101.LAB 474022
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opht-20200930_pre.xml EX-101.PRE 304919
12 EXTRACTED XBRL INSTANCE DOCUMENT opht-20200930_htm.xml XML 840463
Mailing Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119
Business Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36080 | Film No.: 201283811
SIC: 2834 Pharmaceutical Preparations